Literature DB >> 16203945

Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital.

Kevin Purcell1, Jaime Fergie.   

Abstract

BACKGROUND: Previously we reported the rapid emergence and exponential increase of community-acquired (CA) methicillin-resistant Staphylococcus aureus (MRSA) infections in South Texas children.
OBJECTIVE: To assess whether changes have occurred in the frequency, types, susceptibility, and treatment of CAMRSA infections at Driscoll Children's Hospital.
METHODS: Data from 1990 through 2001 were collected during 2 previous studies. Data from 2002 through 2003 were collected and compared with data from 1990 through 2001. All S aureus isolates were identified by a computer-assisted search of culture results, and the medical records were reviewed for all patients with MRSA infections.
RESULTS: A total of 1002 MRSA cases were identified from 1990 through 2003 of which 928 (93%) were community-acquired. The number of CAMRSA cases ranged from 0 to 9 per year from 1990 through 1999 and then increased exponentially from 36 in 2000 to 459 in 2003. The most common type of CAMRSA infection in children without (94%) and with (72%) risk factors was cellulitis and abscess. A higher percentage of children with risk factors had invasive CAMRSA infections (26% vs 3%; P<.001). From 2002 through 2003, there was a significant difference in clindamycin susceptibility between CAMRSA isolates from children without and with risk factors and nosocomial isolates (97% and 86% vs 62%; P<.005). A higher percentage of patients admitted for treatment of CAMRSA infections received an empirical intravenous antibiotic to which the organism was susceptible when comparing 2002-2003 with 1990-2000 (96% vs 15%; P<.001). During this 14-year study, all patients recovered, including those with life-threatening CAMRSA infections.
CONCLUSION: The rapid emergence of CAMRSA as a cause of noninvasive and invasive infections in children, which started occurring in the 1990s, has reached epidemic proportions.

Entities:  

Mesh:

Year:  2005        PMID: 16203945     DOI: 10.1001/archpedi.159.10.980

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  42 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Regulation of host hemoglobin binding by the Staphylococcus aureus Clp proteolytic system.

Authors:  Allison J Farrand; Michelle L Reniere; Hanne Ingmer; Dorte Frees; Eric P Skaar
Journal:  J Bacteriol       Date:  2013-08-30       Impact factor: 3.490

Review 3.  Prevention of Recurrent Staphylococcal Skin Infections.

Authors:  C Buddy Creech; Duha N Al-Zubeidi; Stephanie A Fritz
Journal:  Infect Dis Clin North Am       Date:  2015-09       Impact factor: 5.982

Review 4.  Evidence-based approach to abscess management.

Authors:  Christina Korownyk; G Michael Allan
Journal:  Can Fam Physician       Date:  2007-10       Impact factor: 3.275

5.  Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus.

Authors:  Mary Jo Cenizal; Daniel Skiest; Samuel Luber; Roger Bedimo; Pat Davis; Patrick Fox; Kathleen Delaney; R Doug Hardy
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

6.  Trends in resource utilization for hospitalized children with skin and soft tissue infections.

Authors:  Michelle A Lopez; Andrea T Cruz; Marc A Kowalkowski; Jean L Raphael
Journal:  Pediatrics       Date:  2013-02-25       Impact factor: 7.124

7.  Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective Review.

Authors:  Daniel Rainkie; Mary H H Ensom; Roxane Carr
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

8.  Antibiotic therapy in neonatal and pediatric septic shock.

Authors:  Rajesh K Aneja; Ruby Varughese-Aneja; Carol G Vetterly; Joseph A Carcillo
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

9.  Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.

Authors:  Adam Frymoyer; Adam L Hersh; Leslie Z Benet; B Joseph Guglielmo
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

Review 10.  Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.

Authors:  Jason G Newland; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.